131 related articles for article (PubMed ID: 34055078)
1. Expression and prognostic value of SULT1A2 in bladder cancer.
Chao Y; Ou Q; Shang J
Exp Ther Med; 2021 Jul; 22(1):779. PubMed ID: 34055078
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of CLIC3 mRNA overexpression in bladder cancer.
Chen M; Zhang S; Wen X; Cao H; Gao Y
PeerJ; 2020; 8():e8348. PubMed ID: 31934512
[TBL] [Abstract][Full Text] [Related]
3. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
Shen C; Liu J; Wang J; Yang X; Niu H; Wang Y
Dis Markers; 2020; 2020():4312629. PubMed ID: 32454905
[No Abstract] [Full Text] [Related]
4. HSPB8 is a Potential Prognostic Biomarker that Correlates With Immune Cell Infiltration in Bladder Cancer.
Tan Z; Fu S; Huang Y; Duan X; Zuo Y; Zhu X; Wang H; Wang J
Front Genet; 2022; 13():804858. PubMed ID: 35330734
[No Abstract] [Full Text] [Related]
5. Downregulation of ST3GAL5 is associated with muscle invasion, high grade and a poor prognosis in patients with bladder cancer.
Ouyang S; Liu JH; Ni Z; Ding GF; Wang QZ
Oncol Lett; 2020 Jul; 20(1):828-840. PubMed ID: 32566010
[TBL] [Abstract][Full Text] [Related]
6.
Wang J; Shen C; Zhang J; Zhang Y; Liang Z; Niu H; Wang Y; Yang X
DNA Cell Biol; 2021 Jun; 40(6):798-810. PubMed ID: 34030484
[TBL] [Abstract][Full Text] [Related]
7. Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder.
Wang X; Bai Y; Zhang F; Yang Y; Feng D; Li A; Yang Z; Li D; Tang Y; Wei X; Wei W; Han P
Onco Targets Ther; 2020; 13():9543-9558. PubMed ID: 33061438
[TBL] [Abstract][Full Text] [Related]
8. Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry.
Wu M; Sun Q; Mo CH; Pang JS; Hou JY; Pang LL; Lu HP; Dang YW; Fang SJ; Tang D; Chen G; Feng ZB
Oncol Rep; 2019 Jul; 42(1):151-175. PubMed ID: 31059074
[TBL] [Abstract][Full Text] [Related]
9. MAN1B1 is associated with poor prognosis and modulates proliferation and apoptosis in bladder cancer.
Wang HF; Wu JH; Gai JW; Yang SQ; Ma QT; Ma HS; Feng Q
Gene; 2018 Dec; 679():314-319. PubMed ID: 30218751
[TBL] [Abstract][Full Text] [Related]
10. Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis.
Wang Y; Chen L; Ju L; Qian K; Liu X; Wang X; Xiao Y
Front Oncol; 2019; 9():1030. PubMed ID: 31681575
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.
Xu Z; Zhang Q; Luh F; Jin B; Liu X
Oncol Lett; 2019 Feb; 17(2):1865-1876. PubMed ID: 30675249
[TBL] [Abstract][Full Text] [Related]
12. Attenuated expression of SNF5 facilitates progression of bladder cancer via STAT3 activation.
Ding H; Huang Y; Shi J; Wang L; Liu S; Zhao B; Liu Y; Yang J; Chen Z
Cancer Cell Int; 2021 Dec; 21(1):655. PubMed ID: 34876150
[TBL] [Abstract][Full Text] [Related]
13. Opa interacting protein 5 acts as an oncogene in bladder cancer.
He X; Hou J; Ping J; Wen D; He J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2221-2233. PubMed ID: 28752236
[TBL] [Abstract][Full Text] [Related]
14. Rab22a is a novel prognostic marker for cell progression in breast cancer.
He M; Shen L; Jiang C; Gao G; Wang K; Jiao Y; Sun L; Cui Y; Ke Z; Yang Z
Int J Mol Med; 2020 Apr; 45(4):1037-1046. PubMed ID: 32124943
[TBL] [Abstract][Full Text] [Related]
15. Examination of human tissue cytosols for expression of sulfotransferase isoform 1A2 (SULT1A2) using a SULT1A2-specific antibody.
Nowell S; Green B; Tang YM; Wiese R; Kadlubar FF
Mol Pharmacol; 2005 Feb; 67(2):394-9. PubMed ID: 15528404
[TBL] [Abstract][Full Text] [Related]
16. A Novel Prognostic Biomarker of Luminal Breast Cancer: High CD39 Expression Is Related to Poor Survival.
Ni X; Wan W; Ma J; Liu X; Zheng B; He Z; Yang W; Huang L
Front Genet; 2021; 12():682503. PubMed ID: 34220957
[TBL] [Abstract][Full Text] [Related]
17. Expression and potential prognostic value of histone family gene signature in breast cancer.
Xie W; Zhang J; Zhong P; Qin S; Zhang H; Fan X; Yin Y; Liang R; Han Y; Liao Y; Yu X; Long H; Lv Z; Ma C; Yu F
Exp Ther Med; 2019 Dec; 18(6):4893-4903. PubMed ID: 31772649
[TBL] [Abstract][Full Text] [Related]
18. A novel risk score based on a combined signature of 10 immune system genes to predict bladder cancer prognosis.
Tang Y; Hu Y; Wang J; Zeng Z
Int Immunopharmacol; 2020 Oct; 87():106851. PubMed ID: 32763782
[TBL] [Abstract][Full Text] [Related]
19. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylated
Wang L; Mao Q; Zhou S; Ji X
Onco Targets Ther; 2019; 12():9915-9926. PubMed ID: 31819488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
